Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04483115 |
| Consolidated Lead Sponsor | Vigonvita Life Sciences |
| Therapeutic Condition Cohort | Cardiovascular and Thrombosis |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 60 participants (ACTUAL) |
| Registered Start Date | 2020-11-16 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Peking Union Medical College Hospital | Beijing, China | Open Hospital Dossier -> |
| Peking University First Hospital | Beijing, China | Open Hospital Dossier -> |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, China | Open Hospital Dossier -> |
| The Second Xiangya Hospital of Central South University | Changsha, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.